Roxfarma
Roxfarma is a Peruvian pharmaceutical laboratory founded in 1986 that manufactures generic, branded, and OTC medicines in liquid and semi-solid dosage forms across nine therapeutic lines, serving pharmacy chains, hospitals, government, and distributors in Peru and Bolivia via direct sales and contract manufacturing (maquila).
- Company typePrivate
- Founded1986
- HeadquartersLos Olivos, Peru
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Roxfarma does
Roxfarma (Laboratorio farmacéutico San Joaquín Roxfarma S.A.) is a privately-held Peruvian pharmaceutical laboratory founded in 1986 by Dr. Eleuterio Muñoz Revilla. Headquartered at Av. Alfredo Mendiola 5648, Los Olivos, Lima, the company manufactures generic, branded, and OTC medicines in liquid and semi-solid dosage forms (oral solutions, syrups, suspensions, creams, gels, ointments, and topical solutions) organized into nine therapeutic lines and approximately 90 formulations. Manufacturing operations are certified by DIGEMID for Good Manufacturing Practices (BPM), Good Laboratory Practices (BPL), and Quality Management Systems, with co-located raw materials and finished goods warehouses in the same Lima industrial complex.
Roxfarma operates a dual business model. The first is direct sales of its own branded portfolio across dermatology, pain, gastroenterology, gynecology, pediatrics, respiratory, OTC, generic, and general categories, sold through pharmacy chains (notably Inkafarma and Mifarma), wholesale drugstores (Quirufarma, Grupo Lives, RepCas), independent pharmacies, public hospitals (Hospital Casimiro Ulloa), and government healthcare institutions (EsSalud). The second is a contract manufacturing service (maquila) for pharmacy chains and brand owners in Peru and Bolivia, covering dossier preparation for sanitary registration, R&D, process validation, stability studies, conditioning, and storage — with 15+ years of continuous maquila experience and 35 years of formulation R&D underpinning the offering.
Go-to-market is primarily sales-led B2B, augmented by channel partners (pharmacy chains, drugstores, wholesale distributors), with a nationwide delivery network that includes 48-hour delivery for Lima orders. Marketing is supported by content (a health blog covering preventive care, pediatric and senior health, pharma quality, and production technology) plus organic social presence on LinkedIn, Instagram, Facebook, and TikTok. Revenue is not publicly disclosed; ownership is family-founded with no identified external investors or parent company.
Roxfarma firmographics
Firmographics- Name
- Roxfarma
- Legal name
- Laboratorio farmacéutico San Joaquín Roxfarma S.A.
- Website
- https://roxfarma.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Roxfarma is a Peruvian pharmaceutical laboratory founded in 1986 that manufactures generic, branded, and OTC medicines in liquid and semi-solid dosage forms across nine therapeutic lines, serving pharmacy chains, hospitals, government, and distributors in Peru and Bolivia via direct sales and contract manufacturing (maquila).
- Ownership category
- akta.pro rank
Roxfarma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industries
- OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)
Keywords
Where Roxfarma is headquartered
LocationHeadquarters
- HQ city
- Los Olivos
- HQ country
- Peru
- HQ region
- Latin America
Offices3 records
Markets served
Roxfarma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Direct sales of Roxfarma's own branded pharmaceutical products across multiple therapeutic lines including dermatological, pain, gastroenterological, general, generic, gynecological, OTC, pediatric, and respiratory products. Products sold to pharmacies, drugstores, and healthcare providers throughout Peru.
- Contract Manufacturing (Maquila): Manufacturing services for pharmacy chains and other brand owners. Roxfarma manufactures liquid and semi-solid medicines under client brands, providing comprehensive services from formulation development through packaging and storage. The largest pharmacy chains in Peru and Bolivia trust their maquila services.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Roxfarma product offering
Product offeringCore offering
Roxfarma is a Peruvian pharmaceutical laboratory that manufactures and sells its own branded human-health medicines (oral solutions, syrups, suspensions, creams, gels, ointments, ovules, capsules, and tablets) across nine therapeutic lines, and provides maquila (contract manufacturing) services for liquid and semi-solid medicines under client brands, including dossier preparation, R&D, process validation, stability studies, packaging, and storage. Production runs at a DIGEMID-certified BPM/BPL facility in Lima, serving pharmacy chains, independent pharmacies, drugstores, and public health institutions in Peru and Bolivia.
Product overview
Roxfarma is a Peruvian pharmaceutical laboratory founded in 1986 that manufactures quality medicines for human health. The company operates a portfolio of nine therapeutic product lines (Dermatological, Pain, Gastroenterological, General, Generic, Gynecological, OTC, Pediatric, and Respiratory) containing over 90 individual pharmaceutical products including oral solutions, syrups, suspensions, creams, ointments, gels, ovules, capsules, and tablets. In addition to its own product portfolio, Roxfarma offers comprehensive contract manufacturing services (maquila) for liquid and semi-solid medicines, with capabilities including dossier preparation for sanitary registration, research and development with 90+ available formulas, process validation, product stability studies, conditioning/packaging, and pharmaceutical storage. The company operates with Good Manufacturing Practices (BPM) and Good Laboratory Practices (BPL) certifications from DIGEMID.
Differentiator
Problem solved
Functional benefit
Products and services
- Línea Dermatológica (Dermatological Product Line)
- Línea Dolor (Pain Product Line)
- Línea Gastroenterológica (Gastroenterological Product Line)
- Línea General (General Product Line)
- Línea Genérica (Generic Product Line)
- Línea Ginecológica (Gynecological Product Line)
- Línea OTC (Over-the-Counter Product Line)
- Línea Pediátrica (Pediatric Product Line)
- Línea Respiratoria (Respiratory Product Line)
- Maquila (Contract Manufacturing Services)
Quantifiable outcome
- 35 years of pharmaceutical research, formulation and development experience
- +3 more outcomes
Companies that use Roxfarma
Customer profileNamed customers17 records
Segments4 records
Ideal customer profiles4 records
Roxfarma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Roxfarma partnerships and signals
Strategic signalScale indicators6 records
Recent moves1 record
Expansion highlights5 records
Roxfarma competitors and assessment
Company assessmentRegional players
- Genfar (Grupo Carvajal / Sanofi): Andean regional generic pharmaceuticals manufacturer with strong presence across Peru, Colombia, Ecuador and Bolivia. Particularly comparable to Roxfarma's Bolivia maquila expansion and generic FDF strategy.
- Laboratorios Bagó Perú: Argentine-founded pharmaceutical group with established Peruvian operations producing generics, OTC, and branded specialty products. Comparable therapeutic category coverage but with backing from a larger multinational Latin American player.
Direct peers
- Laboratorios Farmaceuticos Markos: Peruvian pharmaceutical manufacturer with a similar profile: generic and OTC products, national distribution through pharmacy chains, and longstanding presence in the Lima manufacturing market — directly comparable in portfolio breadth and customer base to Roxfarma.
- Laboratorios Portugal (Portugal Pharma): Peruvian pharmaceutical laboratory serving the same pharmacy chain and droguería distribution channels with comparable generic and OTC portfolio. Direct competitor for shelf space at Inkafarma, Mifarma and independent boticas.
- Farmindustria (Grupo Farmindustria): Established Peruvian pharmaceutical laboratory producing branded generics and OTC products sold through pharmacy chains and droguerías. Directly comparable manufacturing footprint, customer set, and therapeutic category breadth.
- Medifarma: One of Peru's largest domestic pharmaceutical laboratories producing branded generics, OTC and prescription medicines. Overlaps with Roxfarma across therapeutic categories, pharmacy chain distribution, and maquila services to chains.
- AC Farma: Peruvian pharmaceutical laboratory specializing in generic and OTC products with manufacturing capabilities supporting national pharmacy distribution. Comparable operating model and customer mix to Roxfarma.
- IQFARMA (Instituto Químico Farmacéutico Nacional): Peruvian pharmaceutical manufacturer focusing on generic and OTC products with national distribution. Comparable scale, regulatory positioning under DIGEMID, and customer overlap with major pharmacy chains.
Broad incumbents
- Bayer Perú: Global pharmaceutical and consumer health incumbent with Peruvian operations spanning OTC (pain, dermatology, respiratory), prescription and crop science. Competes with Roxfarma in shared OTC categories but as part of a much broader portfolio.
- GSK Peru: Multinational pharmaceutical incumbent operating in Peru across OTC, prescription and consumer health. Comparable OTC categories (respiratory, pain, dermatology) but with global brand recognition and broader therapeutic portfolio vs. Roxfarma's local specialist position.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Roxfarma social profiles
Digital presenceRoxfarma compliance and trust
Trust signalCompliance3 records
Roxfarma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Roxfarma leadership team
Management profileNumber of profiles
Roxfarma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Roxfarma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Roxfarma
What does Roxfarma do?
Roxfarma is a Peruvian pharmaceutical laboratory that manufactures and sells its own branded human-health medicines (oral solutions, syrups, suspensions, creams, gels, ointments, ovules, capsules, and tablets) across nine therapeutic lines, and provides maquila (contract manufacturing) services for liquid and semi-solid medicines under client brands, including dossier preparation, R&D, process validation, stability studies, packaging, and storage. Production runs at a DIGEMID-certified BPM/BPL facility in Lima, serving pharmacy chains, independent pharmacies, drugstores, and public health institutions in Peru and Bolivia.
Is Roxfarma a public or private company?
Roxfarma is a private company. It is classified as family owned and is currently operating.
When was Roxfarma founded?
Roxfarma was founded in 1986. It employs 101 to 250 people.
Where is Roxfarma based?
Roxfarma is headquartered in Los Olivos, Peru, in the Latin America region.
How does Roxfarma make money?
Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are contract Manufacturing (Maquila).
Who are Roxfarma's main competitors?
Regional players on record are Genfar (Grupo Carvajal / Sanofi) and Laboratorios Bagó Perú. Direct peers are Laboratorios Farmaceuticos Markos, Laboratorios Portugal (Portugal Pharma), Farmindustria (Grupo Farmindustria), Medifarma, AC Farma and IQFARMA (Instituto Químico Farmacéutico Nacional). Broad incumbents are Bayer Perú and GSK Peru.
Does Roxfarma have an API?
No public API is recorded for Roxfarma.
What industry is Roxfarma in?
Roxfarma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief). Its NAICS code is 325412 and its SIC code is 2834.